FR17C1011I2 - Inhibiteurs de proteasomes - Google Patents
Inhibiteurs de proteasomesInfo
- Publication number
- FR17C1011I2 FR17C1011I2 FR17C1011C FR17C1011C FR17C1011I2 FR 17C1011 I2 FR17C1011 I2 FR 17C1011I2 FR 17C1011 C FR17C1011 C FR 17C1011C FR 17C1011 C FR17C1011 C FR 17C1011C FR 17C1011 I2 FR17C1011 I2 FR 17C1011I2
- Authority
- FR
- France
- Prior art keywords
- proteasome inhibitors
- proteasome
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940079156 Proteasome inhibitor Drugs 0.000 title 1
- 239000003207 proteasome inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2007/017440 WO2009020448A1 (en) | 2007-08-06 | 2007-08-06 | Proteasome inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR17C1011I1 FR17C1011I1 (de) | 2017-05-26 |
| FR17C1011I2 true FR17C1011I2 (fr) | 2018-04-27 |
Family
ID=38691782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR17C1011C Active FR17C1011I2 (fr) | 2007-08-06 | 2017-04-14 | Inhibiteurs de proteasomes |
Country Status (33)
| Country | Link |
|---|---|
| EP (3) | EP2178888B1 (de) |
| JP (1) | JP5261488B2 (de) |
| KR (6) | KR101474831B1 (de) |
| CN (1) | CN101772507B (de) |
| AU (1) | AU2007357338B2 (de) |
| BR (1) | BRPI0721905B8 (de) |
| CA (1) | CA2695082C (de) |
| CY (2) | CY1113386T1 (de) |
| DK (1) | DK2178888T3 (de) |
| EA (1) | EA028622B1 (de) |
| EC (1) | ECSP10010015A (de) |
| ES (1) | ES2390606T3 (de) |
| FR (1) | FR17C1011I2 (de) |
| GE (1) | GEP20125599B (de) |
| HK (2) | HK1143595A1 (de) |
| HR (1) | HRP20120745T1 (de) |
| HU (1) | HUS1700018I1 (de) |
| IL (4) | IL203641A (de) |
| LT (1) | LTC2178888I2 (de) |
| LU (1) | LUC00013I2 (de) |
| MY (1) | MY161991A (de) |
| NL (1) | NL300871I2 (de) |
| NZ (1) | NZ582693A (de) |
| PH (1) | PH12014500053A1 (de) |
| PL (1) | PL2178888T3 (de) |
| PT (1) | PT2178888E (de) |
| RS (1) | RS52435B (de) |
| SG (1) | SG10201508712QA (de) |
| SI (1) | SI2178888T1 (de) |
| TN (1) | TN2010000060A1 (de) |
| UA (1) | UA97536C2 (de) |
| WO (1) | WO2009020448A1 (de) |
| ZA (1) | ZA201000348B (de) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| BRPI0618468A2 (pt) | 2005-11-09 | 2011-08-30 | Proteolix Inc | compostos para inibição de enzima |
| WO2007149512A2 (en) | 2006-06-19 | 2007-12-27 | Proteolix, Inc. | Peptide epoxyketones for pr0teas0me inhibition |
| US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
| MY166950A (en) | 2007-10-04 | 2018-07-25 | Onyx Therapeutics Inc | Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| GEP20135847B (en) | 2008-06-17 | 2013-06-10 | Millennium Pharm Inc | Boronate ester compounds and pharmaceutical compositions containing them |
| AR075090A1 (es) | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
| EP3090737A1 (de) | 2008-10-21 | 2016-11-09 | Onyx Therapeutics, Inc. | Kombinationstherapie mit peptidepoxyketonen |
| TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
| US8853147B2 (en) | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
| AU2010341530B2 (en) | 2009-12-22 | 2016-03-10 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
| MA34133B1 (fr) | 2010-03-01 | 2013-04-03 | Onyx Therapeutics Inc | Composes pour inhibiteurs de l'immunoproteasome |
| AR080863A1 (es) | 2010-03-31 | 2012-05-16 | Millennium Pharm Inc | Derivados del acido1-amino-2-ciclopropiletilboronico, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer. |
| CA2833775A1 (en) * | 2011-06-22 | 2012-12-27 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
| PL2753334T3 (pl) * | 2011-08-30 | 2022-12-12 | Trustees Of Tufts College | Aktywowane przez fap inhibitory proteasomu do leczenia guzów litych |
| US9688702B2 (en) * | 2011-12-22 | 2017-06-27 | Ares Trading | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
| CA2862320A1 (en) * | 2012-01-24 | 2013-08-01 | Millennium Pharmaceuticals, Inc. | Method of treatment of nasopharyngeal cancer |
| EP2810066B1 (de) * | 2012-01-24 | 2019-07-31 | Millennium Pharmaceuticals, Inc. | Verfahren zur behandlung von krebs |
| TW201414751A (zh) | 2012-07-09 | 2014-04-16 | 歐尼克斯治療公司 | 肽環氧酮蛋白酶抑制劑之前驅藥物 |
| CN109180780B (zh) * | 2012-07-26 | 2022-03-18 | 圣特莱国际公司 | 多肽环氧酮化合物 |
| JP2013006855A (ja) * | 2012-09-03 | 2013-01-10 | Millennium Pharmaceuticals Inc | プロテアソーム阻害剤 |
| CA2893460C (en) * | 2012-12-03 | 2018-01-09 | F. Hoffmann-La Roche Ag | Substituted triazole boronic acid compounds |
| JP2016531886A (ja) * | 2013-10-03 | 2016-10-13 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 全身性エリテマトーデス及び／または狼瘡腎炎の予防または治療のための方法 |
| SG10202003693RA (en) | 2014-05-20 | 2020-05-28 | Millennium Pharm Inc | Boron-containing proteasome inhibitors for use after primary cancer therapy |
| WO2016022955A1 (en) | 2014-08-07 | 2016-02-11 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| MA41555A (fr) * | 2015-02-17 | 2017-12-26 | Millennium Pharm Inc | Polythérapie pour le traitement du cancer |
| WO2016205790A2 (en) | 2015-06-19 | 2016-12-22 | Hanlin Scientific, Inc. | Chiral specific boron-containing compounds and their use in treating cancer or amyloidosis |
| CN106608883A (zh) * | 2015-10-21 | 2017-05-03 | 北京大学 | 蛋白酶体抑制剂mln9708的合成方法 |
| CN107400142B (zh) * | 2016-05-19 | 2019-11-19 | 成都奥璟生物科技有限公司 | 一种硼酸和硼酸酯类化合物及其应用 |
| CN106008572B (zh) * | 2016-05-23 | 2018-08-17 | 成都千禧莱医药科技有限公司 | 一类二肽硼酸化合物及制备方法和用途 |
| WO2017222914A1 (en) | 2016-06-21 | 2017-12-28 | Inception 4, Inc. | Carbocyclic prolinamide derivatives |
| CA3025253A1 (en) | 2016-06-21 | 2017-12-28 | Orion Ophthalmology LLC | Heterocyclic prolinamide derivatives |
| CN108368134B (zh) * | 2016-07-25 | 2019-06-14 | 深圳市塔吉瑞生物医药有限公司 | 一种取代的硼酸化合物及包含该化合物的药物组合物及其用途 |
| WO2018133661A1 (zh) * | 2017-01-23 | 2018-07-26 | 成都奥璟生物科技有限公司 | 一种新的硼酸衍生物及其药物组合物 |
| CA3054572A1 (en) | 2017-02-28 | 2018-09-07 | Mayo Foundation For Medical Education And Research | Compounds and methods for treating cancer |
| CN108794516A (zh) * | 2017-04-26 | 2018-11-13 | 上海时莱生物技术有限公司 | 硼酸和硼酸酯类化合物及其制备方法和用途 |
| CN109305980B (zh) * | 2017-07-28 | 2022-10-11 | 成都奥璟生物科技有限公司 | 一种硼酸酯化合物、其合成方法及其用途 |
| ES2901022T3 (es) | 2017-08-25 | 2022-03-21 | Synthon Bv | Procedimiento para la preparación de ixazomib y sus intermedios |
| JP2018024694A (ja) * | 2017-10-03 | 2018-02-15 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | プロテアソーム阻害剤 |
| US11243207B2 (en) | 2018-03-29 | 2022-02-08 | Mayo Foundation For Medical Education And Research | Assessing and treating cancer |
| CN115403603A (zh) * | 2018-09-14 | 2022-11-29 | 成都奥璟生物科技有限公司 | 一种硼酸酯类药物及其用途 |
| CN110357787A (zh) * | 2019-08-02 | 2019-10-22 | 苏州艾和医药科技有限公司 | 依沙佐米合成工艺研究 |
| EP4041246A4 (de) * | 2019-10-07 | 2023-11-01 | Cornell University | Antimikrobielle und antivirale wirkungen von c2-c7alkylboronsäuren |
| CN110950897B (zh) * | 2019-12-12 | 2021-05-28 | 山东大学 | 一种组蛋白去乙酰化酶、蛋白酶体双靶点抑制剂及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4499082A (en) | 1983-12-05 | 1985-02-12 | E. I. Du Pont De Nemours And Company | α-Aminoboronic acid peptides |
| US5187157A (en) | 1987-06-05 | 1993-02-16 | Du Pont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| US5250720A (en) | 1987-06-05 | 1993-10-05 | The Dupont Merck Pharmaceutical Company | Intermediates for preparing peptide boronic acid inhibitors of trypsin-like proteases |
| US5242904A (en) | 1987-06-05 | 1993-09-07 | The Dupont Merck Pharmaceutical Company | Peptide boronic acid inhibitors of trypsin-like proteases |
| EP0315574A3 (de) | 1987-11-05 | 1990-08-22 | Hoechst Aktiengesellschaft | Renin-Inhibitoren |
| US5106948A (en) | 1988-05-27 | 1992-04-21 | Mao Foundation For Medical Education And Research | Cytotoxic boronic acid peptide analogs |
| US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| ES2359391T3 (es) * | 2001-01-25 | 2011-05-23 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Formulación de compuestos de acido boronico. |
| JP4416501B2 (ja) | 2001-05-30 | 2010-02-17 | ノバルティス アクチエンゲゼルシャフト | ２−｛［ｎ−（２−アミノ−３−（ヘテロアリールまたはアリール）プロピオニル）−アミノアシル］−アミノ｝−アルキルボロン酸誘導体 |
| US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| UA88771C2 (ru) * | 2003-08-14 | 2009-11-25 | Сефалон, Инк. | Ингибиторы протеасомы и способ их применения (варианты) |
| US7576206B2 (en) * | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| NZ550522A (en) * | 2004-03-30 | 2010-08-27 | Millennium Pharm Inc | Synthesis of boronic ester and acid compounds |
| WO2006008660A2 (en) | 2004-07-20 | 2006-01-26 | Affinium Pharmaceuticals, Inc. | Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk) |
| TW200618820A (en) * | 2004-11-05 | 2006-06-16 | Alza Corp | Liposome formulations of boronic acid compounds |
| GB0513349D0 (en) | 2005-06-29 | 2005-08-03 | Torres Manel | Non-woven fabric |
| BRPI0612607A2 (pt) | 2005-07-05 | 2010-12-07 | Tufts College | inibidores de alfa proteìna de ativação de fibroblasto |
-
2007
- 2007-08-06 EP EP07811087A patent/EP2178888B1/de active Active
- 2007-08-06 JP JP2010519898A patent/JP5261488B2/ja active Active
- 2007-08-06 KR KR1020107003809A patent/KR101474831B1/ko active IP Right Grant
- 2007-08-06 AU AU2007357338A patent/AU2007357338B2/en active Active
- 2007-08-06 KR KR1020167008358A patent/KR20160040735A/ko not_active Application Discontinuation
- 2007-08-06 PL PL07811087T patent/PL2178888T3/pl unknown
- 2007-08-06 MY MYPI2010000270A patent/MY161991A/en unknown
- 2007-08-06 EP EP16201780.0A patent/EP3210987A1/de active Pending
- 2007-08-06 CN CN2007801001423A patent/CN101772507B/zh active Active
- 2007-08-06 KR KR1020147007078A patent/KR20140042933A/ko active IP Right Grant
- 2007-08-06 EP EP12171220A patent/EP2527347A1/de not_active Withdrawn
- 2007-08-06 RS RS20120405A patent/RS52435B/en unknown
- 2007-08-06 WO PCT/US2007/017440 patent/WO2009020448A1/en active Application Filing
- 2007-08-06 CA CA2695082A patent/CA2695082C/en active Active
- 2007-08-06 EA EA201070247A patent/EA028622B1/ru not_active IP Right Cessation
- 2007-08-06 KR KR1020157000064A patent/KR20150010802A/ko not_active Application Discontinuation
- 2007-08-06 BR BRPI0721905A patent/BRPI0721905B8/pt active IP Right Grant
- 2007-08-06 SG SG10201508712QA patent/SG10201508712QA/en unknown
- 2007-08-06 PT PT07811087T patent/PT2178888E/pt unknown
- 2007-08-06 NZ NZ582693A patent/NZ582693A/en unknown
- 2007-08-06 KR KR1020167036758A patent/KR101831674B1/ko active IP Right Grant
- 2007-08-06 DK DK07811087.1T patent/DK2178888T3/da active
- 2007-08-06 UA UAA201002409A patent/UA97536C2/ru unknown
- 2007-08-06 SI SI200731030T patent/SI2178888T1/sl unknown
- 2007-08-06 GE GEAP200711714A patent/GEP20125599B/en unknown
- 2007-08-06 KR KR1020147007077A patent/KR20140042932A/ko not_active Application Discontinuation
- 2007-08-06 ES ES07811087T patent/ES2390606T3/es active Active
-
2010
- 2010-01-18 ZA ZA2010/00348A patent/ZA201000348B/en unknown
- 2010-02-01 IL IL203641A patent/IL203641A/en active Protection Beyond IP Right Term
- 2010-02-05 TN TNP2010000060A patent/TN2010000060A1/fr unknown
- 2010-03-04 EC EC2010010015A patent/ECSP10010015A/es unknown
- 2010-10-28 HK HK10110167.4A patent/HK1143595A1/xx unknown
-
2012
- 2012-09-17 CY CY20121100845T patent/CY1113386T1/el unknown
- 2012-09-19 HR HRP20120745TT patent/HRP20120745T1/hr unknown
-
2013
- 2013-09-02 HK HK13110199.3A patent/HK1182924A1/zh unknown
-
2014
- 2014-01-06 PH PH12014500053A patent/PH12014500053A1/en unknown
-
2015
- 2015-10-26 IL IL242290A patent/IL242290A/en active IP Right Grant
- 2015-10-26 IL IL242292A patent/IL242292A/en active IP Right Grant
- 2015-10-26 IL IL242291A patent/IL242291A/en active IP Right Grant
-
2017
- 2017-04-05 LU LU00013C patent/LUC00013I2/fr unknown
- 2017-04-06 LT LTPA2017010C patent/LTC2178888I2/lt unknown
- 2017-04-14 FR FR17C1011C patent/FR17C1011I2/fr active Active
- 2017-04-26 CY CY2017016C patent/CY2017016I2/el unknown
- 2017-05-03 HU HUS1700018C patent/HUS1700018I1/hu unknown
- 2017-05-05 NL NL300871C patent/NL300871I2/nl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR17C1011I2 (fr) | Inhibiteurs de proteasomes | |
| CY2020023I1 (el) | Αναστολεiς βητα-λακταμασων | |
| BRPI0807547A2 (pt) | Inibidores de aspartil protease hetercíclicos | |
| CR10831A (es) | INHIBIDORES ESPIRO CETONA DE ACETIL-CoA CARBOXILASA | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| BRPI0810365A2 (pt) | Inibidores de mlc-1 de indol 7-substituído | |
| IT1394247B1 (it) | Dispositivo di serraggio | |
| BRPI0814797A2 (pt) | Inibidores dna-pk | |
| BRPI0807772A2 (pt) | Dispositivo de embalar | |
| BRPI0918564A2 (pt) | inibidores | |
| BRPI0912234A2 (pt) | derivados de salinosporamida como inibidores de proteassomas | |
| FI20085565A (fi) | Tiivistyslaite | |
| AT506380A3 (de) | Stempelvorrichtung | |
| DE602009001221D1 (de) | Abdichtungsvorrichtung | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| BRPI0918966A2 (pt) | inibidores de protease | |
| NO20070960A (no) | Teine | |
| BRPI0919073A2 (pt) | inibidores de protease | |
| GB0707315D0 (en) | Novel proteasome inhibitor | |
| FI20075320A0 (fi) | Uusia käyttökelpoisia inhibiittoreita | |
| ITMI20061754A1 (it) | Dispositivo di smussatura perfezionato |